Protiva Biotherapeutics INC

Protiva is a development stage biotechnology company, focused on pharmaceutical products to fight serious human disease. Protiva's proprietary SNALP technology enables the development of novel nucleic acid-based drugs, such as those that utilize siRNA. Protiva was founded in September of 2000 based on technology developed at The University of British Columbia.Protiva's headquarters is in Seattle, WA and its R&D facility is in Vancouver, B.C. Protiva's incorporation in Delaware is pending

Contact Details: 100-3480 Gilmore Way Burnaby British Columbia V5G 4W7 Canada Tel: 604 630-5061 Fax: 604.630-5103 Email: information@protivabio.com WWW: www.protivabio.com/

Loading...

Recent Publications by Protiva Biotherapeutics INC:
Misinterpreting the therapeutic effects of siRNA caused by immune stimulation. Activation of innate immunity has direct effects in modulating viral...	21st August, 2008	Protiva Biotherapeutics Inc., Burnaby, British Columbia, Canada;	Hum Gene Ther. 2008 Aug 19. DOI Direct Link
Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. An analogous series of cationic lipids...	15th December, 2005	Protiva Biotherapeutics Inc., 100-3480 Gilmore Way, Burnaby, B.C., Canada	J Control Release. 2005 Oct 3;107(2):276-87. DOI Direct Link
A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA. PURPOSE: A fully scalable and extrusion-free method was developed to...	10th August, 2005	Protiva Biotherapeutics Inc., Burnaby, British Columbia, Canada V5G 4Y1.	Pharm Res. 2005 Mar;22(3):362-72.
Stabilized plasmid-lipid particles containing PEG-diacylglycerols exhibit extended circulation lifetimes and tumor selective gene expression. Stabilized plasmid lipid particles (SPLP) consist of a single copy of DNA...	22nd July, 2005	Protiva Biotherapeutics Inc., 100-3480 Gilmore Way, Burnaby, BC, Canada	Biochim Biophys Acta. 2005 May 20;1669(2):155-63. Epub 2005 Feb 24. DOI Direct Link

BioNews Results for Protiva Biotherapeutics INC:
Tekmira Pharmaceuticals Expands Executive Management Team	Healthcare Sales & Marketing Network:  Oct 2 2008 10:37AM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team	Nanotechnology News:  Sep 30 2008 1:59AM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team	BC Technology:  Sep 30 2008 1:06AM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team	TradingMarkets:  Sep 29 2008 3:07PM Matching: protiva biotherapeutics inc
Tekmira Pharmaceuticals Expands Executive Management Team	TMC Net:  Sep 29 2008 4:05PM Matching: protiva biotherapeutics inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Protiva Biotherapeutics INC news.

Protiva Biotherapeutics INC Patents:
US Patent No.	Title
6841537	Combination therapy using nucleic acids and conventional drugs
6410328	Sensitizing cells to compounds using lipid-mediated gene and compound delivery

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 187 times since April 2007, the link to the organisation's website has been followed 37 times

Recent Search Terms used to find this page: Protiva Biotherapeutics Inc | information protivabio com | protiva The University of British Columbia | protiva incorporation | protiva incorporation | protiva incorporation | TEKMIRA AND SPLP TECHNOLOGY | tekmira and SPLP technology | Protiva Vancouver 2000 | .

Search for more companies in Burnaby

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Protiva Biotherapeutics INC